GleamWall
中文EN

INFU InfuSystem Holdings, Inc

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1337013 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.4%
TTM net income YoY70.9%
TTM EPS YoY69.2%
Revenue 3-yr CAGR5.5%
Net income 3-yr CAGR118.3%

Margins

Gross margin57.6%
Operating margin9.8%
Net margin6.5%
FCF margin17.1%
EBITDA margin18.8%

Returns

ROE15.8%
ROA9.3%
ROIC (approx.)13.4%
Asset turnover1.42x

Leverage & solvency

Liabilities / assets38.6%
Debt / equity0.31x
Current ratio2.68x
Interest coverage13.83x

Cash quality & payout

Operating cash flow / net income2.67x
Accruals ratio-15.5%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$37.59M$36.93M$33.68M$36.23M$36.49M$36.00M$34.72M$33.85M
Cost of revenue$15.86M$15.52M$14.00M$15.79M$15.67M$16.13M$15.55M$15.63M
Gross profit$21.73M$21.41M$19.68M$20.43M$20.82M$19.87M$19.17M$18.22M
SG&A expense$14.11M$14.10M$14.80M$14.08M$14.43M$13.15M$15.32M$13.21M
Operating income$4.75M$4.15M$1.59M$3.71M$3.81M$3.78M$618,000$2.62M
Interest expense$257,000$255,000$255,000$260,000$330,000$373,000$336,000$361,000
Pretax income$4.54M$3.87M$1.42M$3.50M$3.43M$3.45M$253,000$2.26M
Income tax$1.39M$640,000$400,000$1.46M$1.17M$847,000$520,000$1.33M
Net income$3.16M$3.23M$1.02M$2.04M$2.26M$2.60M-$267,000$933,000
EBITDA$7.87M$7.33M$4.84M$7.06M$7.09M$7.12M$3.94M$6.04M
EPS (basic)0.160.160.05—0.110.12-0.01—
EPS (diluted)0.150.150.05—0.110.12-0.01—
Weighted avg. shares (diluted)21.07M20.92M20.89M—20.95M21.06M21.13M—
Balance sheet
Cash & equivalents$9.11M$964,000$2.11M$3.19M$955,000$720,000$1.51M$527,000
Receivables$29.55M$27.20M$23.98M$22.90M$24.31M$24.48M$23.89M$21.20M
Inventory$5.15M$5.52M$5.83M$5.39M$5.59M$5.67M$6.09M$6.53M
Current assets$47.91M$38.27M$36.66M$36.34M$35.57M$34.80M$35.32M$32.16M
PP&E, net$2.75M$3.00M$3.22M$3.36M$3.65M$3.81M$3.92M$4.03M
Goodwill$3.71M$3.71M$3.71M$3.71M$3.71M$3.71M$3.71M$3.71M
Intangibles$6.32M$6.48M$6.66M$6.87M$7.08M$7.15M$6.21M$6.46M
Total assets$104.52M$97.70M$98.66M$100.56M$98.88M$100.85M$104.28M$103.61M
Current liabilities$17.87M$15.30M$17.14M$20.18M$18.72M$15.86M$15.97M$17.66M
Short-term debt$0$0$0$0$0$0$0$0
Long-term debt$19.69M$20.42M$19.65M$19.62M$20.93M$26.35M$28.71M$23.86M
Total debt$19.69M$20.42M$19.65M$19.62M$20.93M$26.35M$28.71M$23.86M
Total liabilities$40.37M$38.55M$39.91M$43.23M$43.41M$46.31M$49.13M$46.09M
Shareholders' equity$64.15M$59.15M$58.75M$57.33M$55.47M$54.53M$55.15M$57.53M
Net debt$10.58M$19.46M$17.54M$16.44M$19.98M$25.63M$27.20M$23.34M
Shares outstanding20.03M19.91M20.18M20.21M20.33M20.43M20.97M21.27M
Cash flow statement
Operating cash flow$10.34M$6.78M$970,000$7.13M$8.49M$7.01M$1.78M$7.93M
Capital expenditure$73,000$91,000$157,000$133,000$79,000$217,000$131,000$530,000
Free cash flow$10.27M$6.69M$813,000$6.99M$8.41M$6.79M$1.65M$7.40M
Investing cash flow-$1.97M-$4.52M-$1.26M-$2.19M-$252,000-$1.69M-$2.66M-$3.27M
Financing cash flow-$230,000-$3.40M-$790,000-$2.70M-$8.01M-$6.11M$1.86M-$4.51M
Depreciation & amortization$3.12M$3.17M$3.25M$3.35M$3.28M$3.34M$3.32M$3.42M
Stock-based compensation$1.24M$1.24M$1.23M$1.27M$1.32M$661,000$1.11M$1.18M
Share buybacks$605,000$3.55M$809,000$1.31M$2.17M$3.50M$2.90M$199,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.